Serum coding and non-coding RNAs as biomarkers of NAFLD and fibrosis severity
来源期刊:Digestive and Liver DiseaseDOI:10.1016/J.DLD.2018.11.042
Gastric cancer missed at esophagogastroduodenoscopy in a well-defined Spanish population.
来源期刊:Digestive and Liver DiseaseDOI:10.1016/J.DLD.2019.03.005
Effectiveness and safety of Sofosbuvir/Velpatasvir/Voxilaprevir for retreatment of chronic hepatitis C patients with a previous failure to direct-acting antivirals: a real-life study from the Navigatore Lombardia and Veneto Networks
来源期刊:Digestive and Liver DiseaseDOI:10.1016/j.dld.2018.11.063
AISF position paper on HCV in immunocompromised patients
来源期刊:Digestive and Liver DiseaseDOI:10.1016/J.DLD.2018.09.022
Association between black race and presentation and liver-related outcomes of patients with autoimmune hepatitis
来源期刊:Digestive and Liver DiseaseDOI:10.1016/j.dld.2018.11.068
A new regulator of mitochondrial OXPHOS in hepatocytes and HCC cell lines: the AAA+ ATPase RuvBL1
来源期刊:Digestive and Liver DiseaseDOI:10.1016/j.dld.2018.11.109
Nuclear orphan receptor COUP-TF2 induces anoikis resistance, amoeboid migration and metastatic potential in hepatocellular carcinoma (HCC)
来源期刊:Digestive and Liver DiseaseDOI:10.1016/j.dld.2018.11.106
Real life data on elbasvir/grazoprevir efficacy, safety and drug-drug interaction profile in patients with chronic hepatitis C viral infection: a prospective analysis in the PITER cohort
来源期刊:Digestive and Liver DiseaseDOI:10.1016/j.dld.2018.11.151